Beloranib

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameBeloranib
Drug Alias Name贝洛拉尼Beloranib HemioxalatebeloranibbeloranibumZGN-440 +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMethionine aminopeptidase 2 inhibitorsAngiogenesis inhibitors
TargetsMethionine aminopeptidase 2
Therapy Area/IndicationsWounds and InjuriesOverweightObesity +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesChong Kun Dang Pharmaceutical Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesZafgen Inc
Active IndicationsN/A
Inactive IndicationsWounds and InjuriesOverweightObesity +[6] 

Other Information

ATC CodeN/A
Related LinksWikipedia